ASCO Guidelines

180 Episodio

1. Adjuvant Therapy for Stage II Colon Cancer Guideline Update

   Pubblicato: 22/12/2021
2. Management of Stage III NSCLC Guideline

   Pubblicato: 22/12/2021
3. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

   Pubblicato: 21/12/2021
4. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline

   Pubblicato: 13/12/2021
5. Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

   Pubblicato: 10/12/2021
6. Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)

   Pubblicato: 16/11/2021
7. Ocular Toxicities: Management of irAEs Guideline (Part 12)

   Pubblicato: 15/11/2021
8. Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)

   Pubblicato: 12/11/2021
9. Hematologic Toxicities: Management of irAEs Guideline (Part 10)

   Pubblicato: 11/11/2021
10. Nervous System Toxicities: Management of irAEs Guideline (Part 9)

    Pubblicato: 10/11/2021
11. Renal Toxicities: Management of irAEs Guideline (Part 8)

    Pubblicato: 09/11/2021
12. Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)

    Pubblicato: 08/11/2021
13. Endocrine Toxicities: Management of irAEs Guideline (Part 6)

    Pubblicato: 05/11/2021
14. Lung Toxicities: Management of irAEs Guideline (Part 5)

    Pubblicato: 04/11/2021
15. Gastrointestinal Toxicities: Management of irAEs Guideline (Part 4)

    Pubblicato: 03/11/2021
16. Cutaneous Toxicities: Management of irAEs Guideline (Part 3)

    Pubblicato: 02/11/2021
17. ICPi Overview: Management of irAEs Guideline (Part 1)

    Pubblicato: 01/11/2021
18. CAR-T Cell Therapy: Management of irAEs Guideline (Part 2)

    Pubblicato: 01/11/2021
19. Immunotherapy in Patients with Locally Advanced Esophageal Carcinoma: ASCO Guideline Rapid Recommendation Update

    Pubblicato: 18/08/2021
20. Adjuvant PARP Inhibitors in Patients with High-risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update

    Pubblicato: 03/08/2021